Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd has announced a Board of Directors meeting scheduled for November 14, 2026. The primary agenda is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026, along with the Limited Review Report. Additionally, the meeting will address any other business with the Chairperson's permission. The trading window for designated persons will remain closed from October 1, 2026, until 48 hours after the financial results are declared.

Jeena Sikho Lifecare Limited has announced the launch of eight new Ayurvedic healthcare, wellness, and nutraceutical products. The new additions include 'Acharya Ji Arogyam Vati', 'Acharya Ji Nirogyam Vati', 'Jod Xpert Oil', 'Jod Xpert Roll-On', 'Jod Xpert Tablet', and three variants of 'Nutraceutical Jeena Sikho Plant Protein' (General, Men, Women) in chocolate, mango, and coffee flavors. This expansion aims to strengthen and broaden the company's existing portfolio in the Ayurvedic healthcare and wellness sector. The products are currently targeted for the domestic market. The launch signifies the company's commitment to innovation and market expansion within the health and wellness segment.

Jeena Sikho Lifecare Limited has announced that its hospital located in Raipur, Chhattisgarh, has received accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH). The accreditation, valid until August 20, 2029, covers Panchakarma services and signifies adherence to national quality healthcare standards, patient safety, and operational excellence. The company stated this development is part of its ordinary course of business and does not involve expansion, capacity enhancement, or acquisition.

Bhavna Grover, a promoter of Jeena Sikho Lifecare Limited, has acquired 25,000 equity shares through open market purchases. This transaction increases her total shareholding to 3,03,000 shares, representing 0.24% of the total share capital. Prior to this acquisition, her holding was 2,78,000 shares (0.22%). The total diluted share capital remains unchanged. The acquisition was made via the open market route on September 29, 2026.

Bhavna Grover, a Promoter and Whole Time Director of Jeena Sikho Lifecare Ltd, has purchased 25,000 equity shares through the open market on September 29, 2026. This transaction increases her total shareholding to 3,03,000 shares, representing 0.24% of the total share capital, up from 0.22% prior to the purchase. The acquisition was made via open market purchase. The total equity share capital of the company remains Rs. 24,86,01,460/-.

Bhavna Grover, a promoter of Jeena Sikho Lifecare Limited, has acquired 35,000 equity shares through open market purchases. This transaction increases her total shareholding from 2,43,000 shares (0.20%) to 2,78,000 shares (0.22%). The acquisition represents a 0.02% increase in her stake. The total equity share capital of the company remains unchanged at Rs. 24,86,01,460/-.

Bhavna Grover, a Promoter and Whole Time Director of Jeena Sikho Lifecare Ltd, has purchased 35,000 equity shares through the open market. The transaction, which occurred on September 28, 2026, increased her total shareholding from 0.20% to 0.22% of the company's total share capital. The total number of shares held by Bhavna Grover post-acquisition is 2,78,000. This purchase slightly increased the promoter group's overall shareholding from 63.62% to 63.64%. The company's total equity share capital remains unchanged.

Jeena Sikho Lifecare Limited has announced the closure of its trading window for all designated persons, including directors, KMPs, connected persons, and their immediate relatives. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ended September 30, 2026. During this period, trading in the company's securities is prohibited for these individuals. The specific date for the board meeting to approve these financial results will be communicated separately.

Jeena Sikho Lifecare Ltd has received in-principle approval from BSE Limited for the listing of up to 6,50,000 equity shares of Rs. 2/- each under its Employees Stock Option Scheme 2024 (ESOS 2024). This follows a similar approval from NSE. The total number of shares approved has been adjusted to 6,50,000 post a stock split from Rs. 10/- to Rs. 2/- face value. The company has now secured approvals from both major stock exchanges for its ESOP scheme.

Jeena Sikho Lifecare Ltd. has announced the launch of two new Ayurvedic products: Acharya Ji's Amrit Tattava Vati (60 Tablets) and Acharya Ji's Oja Amrit Vati (60 Tablets). Both products were launched on September 21, 2026, and are targeted for the domestic market. This strategic launch aims to strengthen and expand the company's existing portfolio of Ayurvedic healthcare and wellness products, aligning with its growth objectives in the sector. The disclosure was made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.